A major advance in cancer investigation is arising with the use of mini-antibodies to reactivate dysfunctional p53. This essential malignant protector protein is frequently inactivated in several forms of cancer, https://wiishlist.com/story22777777/vhh-fragments-revive-tumor-suppressor-p53-a-potential-approach-for-cancer-management